January 09, 2014
In its first round of proof-of-concept funding, Drexel Ventures -the University’s new technology accelerator and transfer enterprise- is supporting research that could lead to improved solar cells, new drug therapy for treatment of Parkinson’s Disease, safer chemicals for oil extraction and smarter software system monitoring. Investigators for each project will receive $100,000, from Drexel’s Innovation Fund to show that their research could lead to the creation of a commercially viable product.
